Core Insights - The Chinese pharmaceutical cold chain logistics industry is projected to reach a market size of approximately 28 billion yuan in 2024, with a compound annual growth rate (CAGR) of 14.84% over the past five years [1][3]. Industry Overview - The pharmaceutical cold chain logistics sector involves the management of temperature-sensitive and perishable pharmaceutical products throughout their production, processing, storage, transportation, distribution, and sales processes to ensure product quality and minimize losses [1]. - The largest segments within the cold chain logistics market are IVD (In Vitro Diagnostics) and vaccines, accounting for 27% and 13% of the market share, respectively, in 2023 [3]. Competitive Landscape - Leading companies in the Chinese pharmaceutical cold chain logistics industry include Jiuzhoutong, Sinopharm Holdings, and China Resources Pharmaceutical Group [6]. - Jiuzhoutong focuses on technology-driven comprehensive services in the pharmaceutical industry, enhancing its cold chain logistics network and smart equipment [7]. - Sinopharm Holdings leverages IoT technology to create an integrated information system for cold chain logistics management, ensuring seamless data consistency throughout the logistics process [7]. - China Resources Pharmaceutical Group operates over 430 subsidiaries across 28 provinces, utilizing an advanced temperature-controlled warehouse and a proprietary warehouse management system [7]. - JD Logistics is rapidly building a cold chain delivery system, adhering to strict standards to ensure the efficacy of pharmaceutical products [7]. - SF Express has developed a cold chain logistics service since 2014, supported by a robust transportation network and advanced temperature control technology [7].